Immunoprotective activity and safety of a respiratory syncytial virus vaccine: Mucosal delivery of fusion glycoprotein with a CpG oligodeoxynucleotide adjuvant

被引:46
作者
Prince, GA
Mond, JJ
Porter, DD
Yim, KC
Lan, SJ
Klinman, DM
机构
[1] Vir Syst Inc, Rockville, MD 20850 USA
[2] US FDA, Ctr Biol Evaluat & Res, Sect Retroviral Immunol, Bethesda, MD 20892 USA
[3] Univ Calif Los Angeles, Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA
[4] Biosynexus Inc, Gaithersburg, MD 20877 USA
关键词
D O I
10.1128/JVI.77.24.13156-13160.2003
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
CpG oligodeoxynucleotides (ODN) were identified that stimulated immunoglobulin production and cell proliferation in cotton rat cells in vitro. Three of these ODN were used as a mucosall adjuvant in the noses of cotton rats immunized via this route with respiratory syncytial virus fusion (F) protein. The CpG ODN markedly increased the cotton rat humoral neutralizing-antibody response to respiratory syncytial virus. Such immunized animals had a marked reduction in the production of infectious virus after a live-virus challenge. Animals immunized with the combination of F protein and CpG developed enhanced pulmonary pathology consisting of alveolitis and interstitial pneumonitis after a live-virus challenge. Similar enhanced disease has been seen in cotton rats and children immunized with formalin-inactivated respiratory syncytial virus.
引用
收藏
页码:13156 / 13160
页数:5
相关论文
共 29 条
[1]   Cytokine and chemokine gene expression after primary and secondary respiratory syncytial virus infection in cotton rats [J].
Blanco, JCG ;
Richardson, JY ;
Darnell, MER ;
Rowzee, A ;
Pletneva, L ;
Porter, DD ;
Prince, GA .
JOURNAL OF INFECTIOUS DISEASES, 2002, 185 (12) :1780-1785
[2]   FIELD EVALUATION OF A RESPIRATORY SYNCYTIAL VIRUS VACCINE AND A TRIVALENT PARAINFLUENZA VIRUS VACCINE IN A PEDIATRIC POPULATION [J].
CHIN, J ;
MAGOFFIN, RL ;
SHEARER, LA ;
SCHIEBLE, JH ;
LENNETTE, EH .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1969, 89 (04) :449-+
[3]   AN ANTIGENIC ANALYSIS OF RESPIRATORY SYNCYTIAL VIRUS ISOLATES BY A PLAQUE REDUCTION NEUTRALIZATION TEST [J].
COATES, HV ;
ALLING, DW ;
CHANOCK, RM .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1966, 83 (02) :299-&
[4]  
Collins PL., 2001, FIELDS VIROLOGY, P1443
[5]  
Connor E, 1997, PEDIATRICS, V99, P93
[6]   Familial conformational diseases and dementias [J].
Crowther, DC .
HUMAN MUTATION, 2002, 20 (01) :1-14
[7]   RESPIRATORY VIRUS IMMUNIZATION .I. A FIELD TRIAL OF 2 INACTIVATED RESPIRATORY VIRUS VACCINES - AN AQUEOUS TRIVALENT PARAINFLUENZA VIRUS VACCINE AND AN ALUM-PRECIPITATED RESPIRATORY SYNCYTIAL VIRUS VACCINE [J].
FULGINITI, VA ;
ELLER, JJ ;
SIEBER, OF ;
JOYNER, JW ;
MINAMITANI, M ;
MEIKLEJOHN, G .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1969, 89 (04) :435-+
[8]   Intranasal immunization with CpG oligodeoxynucleotides as an adjuvant dramatically increases IgA and protection against herpes simplex virus-2 in the genital tract [J].
Gallichan, WS ;
Woolstencroft, RN ;
Guarasci, T ;
McCluskie, MJ ;
Davis, HL ;
Rosenthal, KL .
JOURNAL OF IMMUNOLOGY, 2001, 166 (05) :3451-3457
[9]   Immune-mediated disease pathogenesis in respiratory syncytial virus infection [J].
Graham, BS ;
Johnson, TR ;
Peebles, RS .
IMMUNOPHARMACOLOGY, 2000, 48 (03) :237-247
[10]   Respiratory syncytial virus pneumonia among the elderly: An assessment of disease burden [J].
Han, LL ;
Alexander, JP ;
Anderson, LJ .
JOURNAL OF INFECTIOUS DISEASES, 1999, 179 (01) :25-30